AMENDMENT AGREEMENT dated as of October 26, 2020 Between BANK OF AMERICA, N.A. and NUVASIVE, INC.Amendment Agreement • October 29th, 2020 • Nuvasive Inc • Surgical & medical instruments & apparatus • New York
THIS AMENDMENT AGREEMENT (“Amendment Agreement”) with respect to the Warrant Confirmations (as defined below) is made as of October 26, 2020 between NuVasive, Inc. (“Issuer”) and Bank of America, N.A. (“Dealer”).
GENERAL CONSULTING AND SERVICES AGREEMENTGeneral Consulting and Services Agreement • October 29th, 2020 • Nuvasive Inc • Surgical & medical instruments & apparatus • Delaware
This General Consulting and Services Agreement (“Agreement”) is effective as of October 13, 2020 (the “Effective Date”) by and between NuVasive, Inc. (“NuVasive” or the “Company”) and Matthew Link (“Consultant”) (individually referred to as a “Party” or collectively the “Parties”).
AMENDMENT AGREEMENT dated as of October 26, 2020 Between MORGAN STANLEY & CO. INTERNATIONAL PLC. and NUVASIVE, INC.Amendment Agreement • October 29th, 2020 • Nuvasive Inc • Surgical & medical instruments & apparatus • New York
THIS AMENDMENT AGREEMENT (“Amendment Agreement”) with respect to the Warrant Confirmations (as defined below) is made as of October 26, 2020 between NuVasive, Inc. (“Issuer”) and Morgan Stanley & Co. International plc (“Dealer”).
October 13, 2020 Dear Matt,Letter Agreement • October 29th, 2020 • Nuvasive Inc • Surgical & medical instruments & apparatus • Delaware
This letter agreement confirms the terms of your continuing employment relationship with NuVasive, Inc. (the “Company”). The Compensation Committee of the Company’s Board of Directors (the “Board”) has approved the following amendments to your letter agreement dated October 17, 2018 (the “Employment Letter”), to reflect your transition from your current role as the Company’s President as of October 13, 2020, your continued employment with the Company in the capacity of a Special Advisor from October 14, 2020 through December 31, 2020, and your continued service as a consultant for the period January 1, 2021 through March 31, 2021.
AMENDMENT NO. 1 TO PROPRIETARY INFORMATION, INVENTIONS ASSIGNMENT AND RESTRICTIVE COVENANT AGREEMENTAssignment and Restrictive Covenant Agreement • October 29th, 2020 • Nuvasive Inc • Surgical & medical instruments & apparatus • Delaware
THIS AMENDMENT NO. 1 TO PROPRIETARY INFORMATION, INVENTIONS ASSIGNMENT AND RESTRICTIVE COVENANT AGREEMENT (this “Amendment”) is made and entered into by and between Matthew Link (“Shareowner”) and NuVasive, Inc. (the “Company”) (collectively “Parties”), effective October 13, 2020 (the “Effective Date”).
